New NIH grants fuel research in oral cancer treatment and pain relief
Researchers at the School of Dentistry at UT Health San Antonio, the academic health center of The University…
Opioid receptors caught in motion offering clues for safer painkillers
Scientists have known for decades that opioids relieve pain by binding to molecular switches in the brain called…
Scientists uncover new obesity genes that reshape understanding of weight and disease risk
A global research team maps how rare and common gene variants jointly drive obesity and metabolic disease, offering…
Diabetes remission possible with GLP-1 drugs, Italian study confirms
Real-world data from over 14,000 Italian adults reveal that GLP-1 receptor agonists can induce remission in type 2…
Research opens new avenues for treating asthma and other inflammatory diseases
For decades, scientists have thought they understood the biochemical machinery that causes asthma-inflammation in the lungs that constricts…
New study offers hope for patients with treatment-resistant focal epilepsy
About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond…
New personalized therapy boosts tamoxifen effectiveness in breast cancer patients
Breast cancer is the most common cancer among women worldwide (WHO, 2023). The Dr. Margarete Fischer-Bosch Institute of…
Blocking two enzymes weakens prostate tumors and boosts drug effectiveness
A major international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment…
Innovative approaches target PAR2 receptor to alleviate gut pain
Abdominal pain is a hallmark of many digestive disorders, including inflammatory bowel disease and irritable bowel syndrome. In…
Study finds surge in the use of weight loss drugs among bariatric surgery patients
New research findings show a significant increase in the use of weight loss drugs among patients undergoing metabolic…
Discovery of EP2 receptor opens path to pain relief without blocking inflammation
Scientists at the NYU Pain Research Center have identified which receptor in prostaglandins-the hormone-like substance targeted by common…
Genetic modification enhances “living drugs” for blood cancers
CAR T cells are patient-derived, genetically engineered immune cells. They are “living drugs” and constitute a milestone in…